2011 New Mexico Statutes
Chapter 26: Drugs and Cosmetics
Article 2A: Controlled Substances Therapeutic Research, 26-2A-1 through 26-2A-7
Section 26-2A-5: Patient qualification review board; composition; powers and duties.
26-2A-5. Patient qualification review board; composition; powers and duties.
A. The administrator, upon the recommendation of the New Mexico medical society, shall appoint a patient qualification review board to serve at his pleasure. The patient qualification review board shall be comprised of:
(1) a physician licensed to practice medicine in New Mexico and certified by the American board of ophthalmology;
(2) a physician licensed to practice medicine in New Mexico and certified by the American board of internal medicine and also certified in the subspecialty of medical oncology; and
(3) a physician licensed to practice medicine in New Mexico and certified in psychiatry by the American board of psychiatry and neurology.
Members of the board may be reimbursed for their attendance at meetings at the rate of forty dollars ($40.00) per day.
B. The patient qualification review board shall review all applicants for the Lynn Pierson therapeutic research program and their licensed physicians and certify their participation in the program.
C. The patient qualification review board may include other disease groups for participation in the Lynn Pierson therapeutic research program after pertinent medical data have been presented by a physician to both the administrator and the board and after receiving the necessary approval of the food and drug administration, the drug enforcement administration and the national institute on drug abuse.
Disclaimer: These codes may not be the most recent version. New Mexico may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
